Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
19018 | 526 | 25.6 | 51% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
14 | 4 | ORTHOPEDICS//DENTISTRY, ORAL SURGERY & MEDICINE//SPORT SCIENCES | 808941 |
306 | 3 | LOW BACK PAIN//BEZOAR//GEOPHAGY | 40486 |
3567 | 2 | BEZOAR//TRICHOBEZOAR//PHYTOBEZOAR | 1314 |
19018 | 1 | TIZANIDINE//TOLPERISONE//EPERISONE | 526 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | TIZANIDINE | authKW | 1772532 | 11% | 52% | 59 |
2 | TOLPERISONE | authKW | 1114568 | 5% | 80% | 24 |
3 | EPERISONE | authKW | 895637 | 3% | 86% | 18 |
4 | EPERISONE HYDROCHLORIDE | authKW | 464407 | 2% | 100% | 8 |
5 | CYCLOBENZAPRINE | authKW | 355546 | 3% | 44% | 14 |
6 | CENTRALLY ACTING MUSCLE RELAXANT | authKW | 316052 | 1% | 78% | 7 |
7 | DECEREBRATE RIGIDITY | authKW | 313468 | 2% | 60% | 9 |
8 | PRIDINOL MESYLATE | authKW | 261226 | 1% | 75% | 6 |
9 | SKELETAL MUSCLE RELAXANT | authKW | 208978 | 1% | 60% | 6 |
10 | MUSCLE RELAXANT | authKW | 192405 | 4% | 15% | 22 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 3561 | 48% | 0% | 253 |
2 | Clinical Neurology | 876 | 19% | 0% | 99 |
3 | Neurosciences | 224 | 14% | 0% | 75 |
4 | Anesthesiology | 218 | 4% | 0% | 22 |
5 | Medicine, Research & Experimental | 201 | 8% | 0% | 44 |
6 | Medicine, General & Internal | 156 | 10% | 0% | 50 |
7 | Psychiatry | 66 | 5% | 0% | 27 |
8 | Chemistry, Analytical | 65 | 6% | 0% | 33 |
9 | Orthopedics | 65 | 4% | 0% | 19 |
10 | Rheumatology | 51 | 2% | 0% | 11 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PLANNING MANAGEMENT TEAM | 77400 | 0% | 67% | 2 |
2 | POLYCLIN VITTORIO EMANUELE | 77400 | 0% | 67% | 2 |
3 | ABORATING PUBL HLTH ASPECS RHEUMAT DIS | 58051 | 0% | 100% | 1 |
4 | ALESSANDROCE I | 58051 | 0% | 100% | 1 |
5 | ANP OHN PROGRAM | 58051 | 0% | 100% | 1 |
6 | AY KOZHEVNIKOV CHAIR NERVOUS DIS | 58051 | 0% | 100% | 1 |
7 | CHILDREN HLTH SCI | 58051 | 0% | 100% | 1 |
8 | DEV PHARMACEUT TECHNOL | 58051 | 0% | 100% | 1 |
9 | DIPARTIMENTO RIABILITAZIONE | 58051 | 0% | 100% | 1 |
10 | DRUG SAFETY DISPOSIT PHARMACOKINET | 58051 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JAPANESE JOURNAL OF PHARMACOLOGY | 6393 | 4% | 1% | 22 |
2 | FOLIA PHARMACOLOGICA JAPONICA | 6375 | 2% | 1% | 11 |
3 | CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL | 2707 | 3% | 0% | 15 |
4 | ZHURNAL NEVROPATOLOGII I PSIKHIATRII IMENI S S KORSAKOVA | 2468 | 2% | 0% | 12 |
5 | CLINICAL THERAPEUTICS | 1961 | 2% | 0% | 13 |
6 | CURRENT MEDICAL RESEARCH AND OPINION | 1859 | 2% | 0% | 12 |
7 | NEUROPHARMACOLOGY | 1195 | 3% | 0% | 14 |
8 | GENERAL PHARMACOLOGY-THE VASCULAR SYSTEM | 1092 | 1% | 0% | 7 |
9 | GENERAL PHARMACOLOGY | 1081 | 1% | 0% | 4 |
10 | HEADACHE QUARTERLY-CURRENT TREATMENT AND RESEARCH | 1071 | 0% | 1% | 2 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | TIZANIDINE | 1772532 | 11% | 52% | 59 | Search TIZANIDINE | Search TIZANIDINE |
2 | TOLPERISONE | 1114568 | 5% | 80% | 24 | Search TOLPERISONE | Search TOLPERISONE |
3 | EPERISONE | 895637 | 3% | 86% | 18 | Search EPERISONE | Search EPERISONE |
4 | EPERISONE HYDROCHLORIDE | 464407 | 2% | 100% | 8 | Search EPERISONE+HYDROCHLORIDE | Search EPERISONE+HYDROCHLORIDE |
5 | CYCLOBENZAPRINE | 355546 | 3% | 44% | 14 | Search CYCLOBENZAPRINE | Search CYCLOBENZAPRINE |
6 | CENTRALLY ACTING MUSCLE RELAXANT | 316052 | 1% | 78% | 7 | Search CENTRALLY+ACTING+MUSCLE+RELAXANT | Search CENTRALLY+ACTING+MUSCLE+RELAXANT |
7 | DECEREBRATE RIGIDITY | 313468 | 2% | 60% | 9 | Search DECEREBRATE+RIGIDITY | Search DECEREBRATE+RIGIDITY |
8 | PRIDINOL MESYLATE | 261226 | 1% | 75% | 6 | Search PRIDINOL+MESYLATE | Search PRIDINOL+MESYLATE |
9 | SKELETAL MUSCLE RELAXANT | 208978 | 1% | 60% | 6 | Search SKELETAL+MUSCLE+RELAXANT | Search SKELETAL+MUSCLE+RELAXANT |
10 | MUSCLE RELAXANT | 192405 | 4% | 15% | 22 | Search MUSCLE+RELAXANT | Search MUSCLE+RELAXANT |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | WAGSTAFF, AJ , BRYSON, HM , (1997) TIZANIDINE - A REVIEW OF ITS PHARMACOLOGY, CLINICAL EFFICACY AND TOLERABILITY IN THE MANAGEMENT OF SPASTICITY ASSOCIATED WITH CEREBRAL AND SPINAL DISORDERS.DRUGS. VOL. 53. ISSUE 3. P. 435-452 | 56 | 84% | 106 |
2 | QUASTHOFF, S , MOCKEL, C , ZIEGLGANSBERGER, W , SCHREIBMAYER, W , (2008) TOLPERISONE: A TYPICAL REPRESENTATIVE OF A CLASS OF CENTRALLY ACTING MUSCLE RELAXANTS WITH LESS SEDATIVE SIDE EFFECTS.CNS NEUROSCIENCE & THERAPEUTICS. VOL. 14. ISSUE 2. P. 107 -119 | 47 | 75% | 10 |
3 | KAMEN, L , HENNEY, HR , RUNYAN, JD , (2008) A PRACTICAL OVERVIEW OF TIZANIDINE USE FOR SPASTICITY SECONDARY TO MULTIPLE SCLEROSIS, STROKE, AND SPINAL CORD INJURY.CURRENT MEDICAL RESEARCH AND OPINION. VOL. 24. ISSUE 2. P. 425 -439 | 38 | 62% | 27 |
4 | HENNEY, HR , RUNYAN, JD , (2008) A CLINICALLY RELEVANT REVIEW OF TIZANIDINE HYDROCHLORIDE DOSE RELATIONSHIPS TO PHARMACOKINETICS, DRUG SAFETY AND EFFECTIVENESS IN HEALTHY SUBJECTS AND PATIENTS.INTERNATIONAL JOURNAL OF CLINICAL PRACTICE. VOL. 62. ISSUE 2. P. 314 -324 | 23 | 100% | 10 |
5 | SCHWARZ, M , (2009) TOLPERISONE.PSYCHOPHARMAKOTHERAPIE. VOL. 16. ISSUE 1. P. 2 -7 | 26 | 76% | 2 |
6 | VITALE, DC , PIAZZA, C , SINAGRA, T , URSO, V , CARDI, F , DRAGO, F , SALOMONE, S , (2013) PHARMACOKINETIC CHARACTERIZATION OF TIZANIDINE NASAL SPRAY, A NOVEL INTRANASAL DELIVERY METHOD FOR THE TREATMENT OF SKELETAL MUSCLE SPASM.CLINICAL DRUG INVESTIGATION. VOL. 33. ISSUE 12. P. 885-891 | 21 | 68% | 1 |
7 | AL-GHAZAWI, M , ALZOUBI, M , FAIDI, B , (2013) PHARMACOKINETIC COMPARISON OF TWO 4 MG TABLET FORMULATIONS OF TIZANIDINE.INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS. VOL. 51. ISSUE 3. P. 255-262 | 16 | 84% | 0 |
8 | HENNEY, HR , FITZPATRICK, A , STEWART, J , RUNYAN, JD , (2008) RELATIVE BIOAVAILABILITY OF TIZANIDINE HYDROCHLORIDE CAPSULE FORMULATION COMPARED WITH CAPSULE CONTENTS ADMINISTERED IN APPLESAUCE: A SINGLE-DOSE, OPEN-LABEL, RANDOMIZED, TWO-WAY, CROSSOVER STUDY IN FASTED HEALTHY ADULT SUBJECTS.CLINICAL THERAPEUTICS. VOL. 30. ISSUE 12. P. 2263 -2271 | 17 | 85% | 4 |
9 | KADDAR, N , VIGNEAULT, P , PILOTE, S , PATOINE, D , SIMARD, C , DROLET, B , (2012) TIZANIDINE (ZANAFLEX): A MUSCLE RELAXANT THAT MAY PROLONG THE QT INTERVAL BY BLOCKING I-KR.JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS. VOL. 17. ISSUE 1. P. 102-109 | 18 | 72% | 2 |
10 | FARKAS, S , (2006) SILPERISONE: A CENTRALLY ACTING MUSCLE RELAXANT.CNS DRUG REVIEWS. VOL. 12. ISSUE 3-4. P. 218-235 | 17 | 85% | 8 |
Classes with closest relation at Level 1 |